COST-EFFECTIVENESS OF SYSTEMATIC SCREENING AND TREATMENT OF TRANSTHYRETIN AMYLOID CARDIOMYOPATHY (ATTR-CM) IN PATIENTS WITH HEART FAILURE WITH PRESERVED EJECTION FRACTION (HFPEF) IN UNITED STATES

被引：0
|
作者：
Lau, Anson Tsz Chun [1 ]
DiDomenico, Robert J., Jr. [1 ]
Kim, Kibum [1 ]
机构：
[1] Univ Illinois, Dept Pharm Syst Outcomes & Policy, Chicago, IL USA
来源：
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY | 2023年 / 81卷 / 08期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
1106-003
引用
收藏
页码：400 / 400
页数：1
相关论文
共 50 条
  • [1] Cost-effectiveness of systematic screening and treatment of transthyretin amyloid cardiomyopathy (ATTR-CM) in patients with heart failure with preserved ejection fraction (HFpEF) in United States
    Lau, Anson T. C.
    Didomenico, Robert J.
    Kim, Kibum
    INTERNATIONAL JOURNAL OF CARDIOLOGY, 2024, 398
  • [2] A simple ATTR-CM score to identify transthyretin amyloid cardiomyopathy burden in HFpEF patients
    Ye, Min
    Liu, Xiao
    Gu, Zhenbang
    Sun, Junyi
    Dong, Yugang
    Chen, Yili
    Liu, Chen
    Wu, Zexuan
    Zhu, Wengen
    EUROPEAN JOURNAL OF CLINICAL INVESTIGATION, 2023,
  • [3] Diagnostic Tests Used to Identify Transthyretin Amyloid Cardiomyopathy (ATTR-CM) in the United States
    Brown, Sarah
    Chung, Wei Yen
    Deemer, James
    Melinis, Niya
    Wright, Devon
    CIRCULATION, 2021, 144
  • [4] Prevalence of Transthyretin Amyloid Cardiomyopathy in Heart Failure With Preserved Ejection Fraction
    AbouEzzeddine, Omar F.
    Davies, Daniel R.
    Scott, Christopher G.
    Fayyaz, Ahmed U.
    Askew, J. Wells
    McKie, Paul M.
    Noseworthy, Peter A.
    Johnson, Geoffrey B.
    Dunlay, Shannon M.
    Borlaug, Barry A.
    Chareonthaitawee, Panithaya
    Roger, Veronique L.
    Dispenzieri, Angela
    Grogan, Martha
    Redfield, Margaret M.
    JAMA CARDIOLOGY, 2021, 6 (11) : 1267 - 1274
  • [5] Race, Sex, and Ejection Fraction-Based Differences in Transthyretin Amyloid Cardiomyopathy (ATTR-CM) Risk Prediction
    El Helou, Michel Chedid
    Gupta, Mohak
    Hussain, Muzna
    Hanna, Mazen
    Blumer, Vanessa
    William, Preethi
    Desai, Milind Y.
    Abadie, Bryan Q.
    Ives, Lauren
    Tang, W. H. Wilson
    Jaber, Wael A.
    Collier, Patrick
    Martyn, Trejeeve
    JOURNAL OF CLINICAL MEDICINE, 2024, 13 (20)
  • [6] Cost-Effectiveness of Empagliflozin in Patients With Heart Failure and Preserved Ejection Fraction
    Zhou, Jennifer
    Liew, Danny
    Kaye, David M.
    Zoungas, Sophia
    Stub, Dion
    CIRCULATION-CARDIOVASCULAR QUALITY AND OUTCOMES, 2022, 15 (10): : E008638
  • [7] Cost-effectiveness of Empagliflozin in Patients With Heart Failure With Preserved Ejection Fraction
    Zheng, Jimmy
    Parizo, Justin T.
    Spertus, John A.
    Heidenreich, Paul A.
    Sandhu, Alexander T.
    JAMA INTERNAL MEDICINE, 2022, 182 (12) : 1278 - 1288
  • [8] Transthyretin amyloid cardiomyopathy among patients with heart failure and preserved ejection fraction: the AMY score
    Gioia, Guglielmo
    Schrutka, Lore
    Jozwiak-Nozdrzykowska, Joanna
    Kresoja, Karl-Patrik
    Gunold, Hilka
    Klingel, Karin
    Thiele, Holger
    Bonderman, Diana
    Lurz, Philipp
    Rommel, Karl-Philipp
    ESC HEART FAILURE, 2024, 11 (04): : 2172 - 2181
  • [9] Cost-Effectiveness Analysis of Empagliflozin for Treatment of Patients With Heart Failure With Reduced Ejection Fraction in the United States
    Reifsnider, Odette S.
    Tafazzoli, Ali
    Linden, Stephan
    Ishak, Jack
    Rakonczai, Pal
    Stargardter, Matthew
    Kuti, Effie
    JOURNAL OF THE AMERICAN HEART ASSOCIATION, 2024, 13 (04):
  • [10] Prevalence of transthyretin amyloid cardiomyopathy in patients hospitalised for heart failure with preserved ejection fraction in an LATAM center
    Decotto, S.
    Villar, G. Fernandez
    De Arenaza, D. Perez
    Villanueva, E.
    Lucas, L.
    Del Castillo, S.
    Rossi, E.
    Belziti, C.
    Pizarro, R.
    EUROPEAN HEART JOURNAL, 2024, 45
12345